WuXi AppTec is a global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization) that provides integrated end-to-end R&D and manufacturing services to advance healthcare innovation. The company operates across Asia, Europe, and North America, supporting partners in over 30 countries to bring breakthrough treatments to patients.
AI named WuXi AppTec from September 2026 to October 2026.
Brand page for wuxiapptec-com